Skip to main content Skip to search Skip to main navigation

What is confirmed by the written confirmation for imported APIs?

The written confirmation confirms the following:
• The GMP standards applicable to the third-country active substance manufacturer are at least equivalent to those laid down by the European Union.
• The manufacturing plant in the third country is subject to regular, strict and transparent controls and to repeated and unannounced inspections, so as to ensure the effective implementation of GMP standards by the competent authority in the third country and to assure supervision by the competent authority that is at least equivalent to EU requirements.
• Any reports of non-compliance shall be communicated to the European Union without delay.

[GMP Compliance Adviser, Chapter 20.B]

Would you like to discover more?

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

How is a QRM process initiated?

How is a QRM process initiated?

You can view the answer here:
Read more
FDA: Updated Pre-RFD Guidance for Combination Products

FDA: Updated Pre-RFD Guidance for Combination Products

The U.S. FDA has released an updated final guidance on preparing a Pre-Request for Designation (Pre-RFD), replacing the previous 2018 version. The revised document provides new recommendations for interacting with the Office of Combination Products (OCP) and clarifies expectations for Pre-RFD submissions.
Read more
EDQM: 9 Virtual Training Modules on Ph. Eur. and CEPs

EDQM: 9 Virtual Training Modules on Ph. Eur. and CEPs

The EDQM has introduced a modular training programme covering chemically defined active substances and medicinal products. It will take place between 1 and 12 December 2025.
Read more
Previous
Next